LANCET ONCOLOGY SCIE

中文简介

由柳叶刀出版。国际标准书号：1470-2045。《柳叶刀肿瘤学》是一本月刊，评论期刊，在肿瘤学上发表文章、观点、新闻和评论。历史《柳叶刀肿瘤学》于2000年9月出版，是一本生动、内容丰富的月刊，涵盖了与全球临床癌症专家相关的国际问题。2005年5月，《华尔街日报》扩大了原有的研究范围，并在印刷出版之前首先在网上发表文章。该杂志很快成为世界上最重要的原始研究出版物之一，特别是临床试验报告，以及在倡导和全球卫生领域。唯一的是，所有的原始研究都是通过一个快速的服务进行同行评审的，成功的论文在提交后的8周内发表。2008年，《华尔街日报》将其在线业务扩展到定期播客。柳叶刀肿瘤学也因主办肿瘤学家、癌症研究者和决策者的活动而享有盛誉。2007年，柳叶刀肿瘤学在新加坡召开了第一次会议，题为“21世纪的亚洲和癌症管理”。另外，在2007，该杂志在旧金山、CA、美国的肿瘤学大会上主持了一个关于发展生物学、自我更新和癌症的专题讲座。随后几年，该杂志在2008年肿瘤大会和2009年亚洲肿瘤峰会上主持了第二次全体会议。2010年，柳叶刀肿瘤学“参与”会议的活动进一步扩大，包括在印度尼西亚巴厘岛举行的第二次亚洲肿瘤学峰会，以及在荷兰阿姆斯特丹举行的关于人乳头状瘤病毒和癌症的会议。自2011年以来，《柳叶刀》继续主办成功的亚洲肿瘤峰会，2015年，《柳叶刀》将在中国上海举办2015年4月10日至12日举行的第七届亚洲肿瘤峰会。计划在2016年及以后举办更多活动。该杂志还通过与特定组织和社会合作，参与癌症健康保健的宣传。声誉和影响柳叶刀肿瘤学的影响因子为24.725。该期刊在全球202种肿瘤期刊中排名第三，是领先的临床肿瘤研究期刊，在全球任何学科的所有科学期刊中排名前0.5%（2013年期刊引文报告，汤森路透2014年）。发表在《柳叶刀肿瘤学》上的文章定期在主流印刷媒体、在线媒体和广播媒体上得到报道。新闻报道柳叶刀肿瘤学的目的是发表有趣的，信息丰富的，实践变化的文章，任何与临床肿瘤学相关的主题。主题包括但不限于：乳腺癌内分泌系统癌胃肠道癌泌尿生殖癌妇科癌症血液学癌症头颈癌神经肿瘤学儿科肿瘤学胸肿瘤肉瘤皮肤癌流行病学、癌症预防和癌症控制支持性护理成像卫生保健系统

投稿网址：http://ees.elsevier.com/thelancetoncology/

英文简介

PUBLISHED BY THE LANCET. ISSN: 1470-2045.THE LANCET ONCOLOGY IS A MONTHLY, REVIEW JOURNAL, WITH ARTICLES, VIEWPOINTS, NEWS AND REVIEWS IN ONCOLOGY.HISTORYTHE LANCET ONCOLOGY WAS LAUNCHED IN SEPTEMBER, 2000, AS A LIVELY AND INFORMATIVE MONTHLY JOURNAL COVERING INTERNATIONAL ISSUES RELEVANT TO CLINICAL CANCER SPECIALISTS WORLDWIDE. IN MAY, 2005, THE JOURNAL EXPANDED TO INCLUDE ORIGINAL RESEARCH AND BEGAN PUBLISHING ARTICLES ONLINE FIRST PRIOR TO PRINT PUBLICATION. THE JOURNAL QUICKLY ESTABLISHED ITSELF AS ONE OF THE PREMIER PUBLICATIONS WORLDWIDE FOR ORIGINAL RESEARCH, ESPECIALLY REPORTS FROM CLINICAL TRIALS, AND IN THE AREAS OF ADVOCACY AND GLOBAL HEALTH. UNIQUELY, ALL ORIGINAL RESEARCH IS PEER-REVIEWED VIA A FAST-TRACK SERVICE, AND SUCCESSFUL PAPERS ARE PUBLISHED WITHIN 8 WEEKS OF SUBMISSION. IN 2008, THE JOURNAL EXPANDED ITS ONLINE PRESENCE TO INCLUDE REGULAR PODCASTS.THE LANCET ONCOLOGY HAS ALSO DEVELOPED A REPUTATION FOR HOSTING EVENTS FOR ONCOLOGISTS, CANCER RESEARCHERS, AND POLICYMAKERS. IN 2007, THE LANCET ONCOLOGY CONVENED ITS FIRST CONFERENCE IN SINGAPORE ENTITLED ASIA AND CANCER MANAGEMENTIN THE 21ST CENTURY. ADDITIONALLY IN 2007, THE JOURNAL HOSTED A PLENARY LECTURE AT THE ONCOLOGY CONGRESS IN SAN FRANCISCO, CA, USA, ON THE TOPIC OF DEVELOPMENTAL BIOLOGY, SELF RENEWAL, AND CANCER. IN SUBSEQUENT YEARS, THE JOURNAL HOSTED A SECOND PLENARY LECTURE AT THE 2008 ONCOLOGY CONGRESS, AND THE INAUGURAL ASIAN ONCOLOGY SUMMIT IN 2009. IN 2010, THE LANCET ONCOLOGY''''''''S INVOLVEMENT IN CONFERENCES EXPANDED WITH FURTHER EVENTS, INCLUDING A SECOND ASIAN ONCOLOGY SUMMIT IN BALI, INDONESIA, AND A CONFERENCE ON HPV AND CANCER IN AMSTERDAM, THE NETHERLANDS. SINCE 2011, THE JOURNAL HAS CONTINUED TO HOST THE SUCCESSFUL ASIAN ONCOLOGY SUMMITS AND IN 2015, THE LANCET ONCOLOGY WILL HOST THE 7TH ASIAN ONCOLOGY SUMMIT TO TAKE PLACE APRIL 10-12, 2015 IN SHANGHAI, CHINA. FURTHER EVENTS ARE PLANNED FOR 2016 AND BEYOND. THE JOURNAL IS ALSO INVOLVED IN CANCER HEALTH-CARE ADVOCACY BY PARTNERING WITH SPECIFIC ORGANISATIONS AND SOCIETIES.REPUTATION AND IMPACTTHE LANCET ONCOLOGY HAS AN IMPACT FACTOR OF 24·725. THE JOURNAL RANKS THIRD OUT OF 202 ONCOLOGY JOURNALS WORLDWIDE, IS THE LEADING CLINICAL ONCOLOGY RESEARCH JOURNAL, AND IS IN THE TOP 0·5% OF ALL SCIENTIFIC JOURNALS, OF ANY DISCIPLINE, GLOBALLY (2013 JOURNAL CITATION REPORTS?, THOMSON REUTERS 2014). ARTICLES PUBLISHED IN THE LANCET ONCOLOGY REGULARLY RECEIVE COVERAGE IN THE MAINSTREAM PRINT, ONLINE, AND BROADCAST MEDIA.COVERAGETHE AIM OF THE LANCET ONCOLOGY IS TO PUBLISH INTERESTING, INFORMATIVE, AND PRACTICE-CHANGING ARTICLES ON ANY TOPIC CONNECTED WITH CLINICAL ONCOLOGY. TOPICS INCLUDE, BUT ARE NOT LIMITED TO: BREAST CANCER ENDOCRINE SYSTEM CANCER GASTROINTESTINAL CANCER GENITOURINARY CANCER GYNAECOLOGICAL CANCER HAEMATOLOGICAL CANCER HEAD AND NECK CANCER NEUROONCOLOGY PAEDIATRIC ONCOLOGY THORACIC ONCOLOGY SARCOMA SKIN CANCER EPIDEMIOLOGY, CANCER PREVENTION, AND CANCER CONTROL SUPPORTIVE CARE IMAGING HEALTH-CARE SYSTEMS